Market News & Trends
Centrix Pharma Solutions and University of Sussex partner to advance data-driven pharmaceutical development
Centrix Pharma Solutions, a UK-based Contract Development Manufacturing Organization (CDMO) with strong scientific and manufacturing expertise, has partnered with the University of Sussex on a…
McKesson Signs Agreement to Acquire Precision Medicine Group, LLC
McKesson Corporation announced today that it signed a definitive agreement to acquire Precision Medicine Group, LLC, a global provider of clinical research and biopharma commercialization…
Hovione Completes Expansion of Loures Tablet Manufacturing Center Adding Commercial-Scale Batch Tableting Capacity
LOURES, Portugal – Hovione, a globally-integrated specialist pharmaceutical CDMO, has completed expansion of the company’s tablet development and manufacturing center at its main global campus…
Aptar Active Material Science first use of Activ-Film technology with a commercialized capsule-based Dry Powder Inhalation (DPI) drug product.
Aptar Active Material Science, part of AptarGroup, Inc. and a global leader in active material science solutions, announced its first use of Activ-Film technology with…
FDA Approves IMAAVY (nipocalimab-aahu) for the treatment of warm autoimmune hemolytic anemia
The U.S. FDA approved IMAAVY (nipocalimab-aahu) for the treatment of warm autoimmune hemolytic anemia (wAIHA) - a rare, life-threatening autoantibody disease - in adults and pediatric…
Purdue small-molecule inhibitors shown to promote robust antitumor immunity
WEST LAFAYETTE, Ind. — Researchers in Purdue University’s College of Pharmacy have developed and validated a novel series of small-molecule inhibitors that promote antitumor immunity and hold…
Erasca Granted FDA Fast Track Designation for Pan-RAS Molecular Glue ERAS-0015
SAN DIEGO, -- Erasca, Inc. , a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers,…
Smithers Germany Medical Device Testing Lab Achieves ISO/IEC 17025 Accreditation
(Akron, Ohio, USA) — Smithers, a leading provider of testing, consulting, information, and compliance services, announces that its Germany Medical Device Testing laboratory is formally…
Evonik provides customers with Life Cycle Assessment data for selected EUDRAGIT polymers
Essen, Germany. Evonik now offers its customers cradle-to-gate LCA data for selected EUDRAGIT functional polymers. These results are derived from Evonik’s TÜV-certified LCA method. This…
Bespak Awarded Gold EcoVadis Sustainability Rating for its Holmes Chapel Site
Holmes Chapel, UK, Bespak, the specialist inhalation CDMO, has achieved a Gold EcoVadis sustainability rating for its Holmes Chapel site. The result places Bespak among…
Lonza Launches Rapid Custom Media Prototyping Service to Accelerate Early Bioprocess Development
Basel, Switzerland – Lonza, a leading contract development and manufacturing organization (CDMO), today announced its Rapid Media Prototyping Service (RaMP), giving biopharmaceutical companies faster access…
SGS enhances bioanalytical capacity with Saint-Benoît laboratory expansion
Baar – SGS, the world’s leading testing, inspection and certification company, has expanded its Saint-Benoît laboratory, a strategic site dedicated to pharmaceutical bioanalysis and drug…
Grifols announces Last Patient Last Visit in SPARTA, its Phase 3 Outcomes Study of Prolastin®-C in patients with emphysema due to alpha-1 antitrypsin deficiency
Barcelona, Spain, – Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced the completion of the clinical portion of SPARTA (Study of ProlAstin-C Randomized Therapy…
Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas
PRINCETON, N.J.- Bristol Myers Squibb today announced the selection of Houston, Texas, as the site for a new, state-of-the-art multi-modal manufacturing campus, representing an approximately…
Kupando Announces First Patient Dosed in Phase 1 Clinical Study of Lead Candidate KUP101 in Advanced Solid Tumors
SCHÖNEFELD, Germany, -- Kupando, a pioneering biopharmaceutical company developing a TLR 4/7 agonist that stimulates innate immunity and induces trained immunity for use in oncology…
FDA Approves the First Ever mRNA Flu Vaccine From Moderna
The FDA approved Moderna’s mRNA vaccine, mFlusiva, to prevent seasonal influenza in adults 50 years of age and older. This marks the first ever approval…
ILC Dover Introduces EZJetFlo Technology to Transform Powder Dissolution and Mixing in Biopharmaceutical Manufacturing
FREDERICA, Del., -- ILC Dover, an Ingersoll Rand business and world leader in the innovative design and production for biopharmaceutical, pharmaceutical, and medical device markets,…
LTS Breaks Ground on Major Expansion to Advance Drug Delivery Innovation and North American Growth
West St. Paul, Minnesota / Andernach, Germany, – LTS Lohmann Therapie-Systeme AG (LTS), a leading partner in innovative drug delivery technologies, today celebrated the groundbreaking…
Enzene launches NeX, a comprehensive suite of solutions to enable cost-efficient, high-yielding local biomanufacturing
Pune, India - Enzene, a leading global continuously innovative development and manufacturing organization (CIDMO™), today announced the launch of NeX, a transformative end-to-end partnership model…
Obsidian Therapeutics Completes Closing of Transaction with Galera Therapeutics and Previously Announced Private Placement of $350 Million
CAMBRIDGE, Mass., Obsidian Therapeutics, Inc., a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies, today announced the completion…
